{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T11:59:52Z","timestamp":1742385592169,"version":"3.37.0"},"reference-count":13,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["eJHaem"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This report describes the characteristics and outcomes of 18 heavily pretreated patients with multiple myeloma (MM) who were subsequently treated with selinexor. This is a case series of 18 patients with MM who were treated with selinexor and dexamethasone (Sd) or selinexor, bortezomib, and dexamethasone (SVd) in 12 hospitals in the UK between 2019 and 2021. Eight patients received Sd and 10 patients received SVd. Patients received a median of five prior treatment lines, including immunomodulatory agents in 94% and proteasome inhibitors in 94%. Ten patients (55%) had triple\u2010class refractory disease. Six of the 12 evaluable patients achieved \u2265partial response. The median progression\u2010free survival was 5.6\u00a0months, which was higher with SVd (5.7\u00a0months) than with Sd (2.1\u00a0months). The results support a treatment benefit of selinexor in heavily pretreated patients and support the notion that selinexor may overcome resistance to prior therapies, with no new safety concerns arising.<\/jats:p>","DOI":"10.1002\/jha2.913","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:49:08Z","timestamp":1723006148000},"page":"987-991","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case series"],"prefix":"10.1002","volume":"5","author":[{"given":"Nini","family":"Aung","sequence":"first","affiliation":[{"name":"North Tees and Hartlepool NHS Foundation Trust Stockton\u2010on\u2010Tees  Hartlepool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Bowers","sequence":"additional","affiliation":[{"name":"Ulster Hospital Southeastern Health and Social Care Trust  Dundonald UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Brearton","sequence":"additional","affiliation":[{"name":"Clatterbridge Cancer Centre NHS Foundation Trust  Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-0556","authenticated-orcid":false,"given":"Andrew","family":"Charlton","sequence":"additional","affiliation":[{"name":"The Newcastle upon Tyne Hospitals NHS Foundation Trust  Newcastle Upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Craig","sequence":"additional","affiliation":[{"name":"Raigmore Hospital  Inverness UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Cullis","sequence":"additional","affiliation":[{"name":"Salisbury NHS Foundation Trust  Salisbury UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Dang","sequence":"additional","affiliation":[{"name":"South Tees Hospitals NHS Foundation Trust  Middlesbrough UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Donaldson","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust  Belfast UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Drake","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust  Belfast UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Hall","sequence":"additional","affiliation":[{"name":"University Hospitals  Dorset UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Parkins","sequence":"additional","affiliation":[{"name":"Royal Cornwall Hospitals NHS Trust  Truro UK"},{"name":"NHS Grampian  Aberdeen UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Tighe","sequence":"additional","affiliation":[{"name":"NHS Grampian  Aberdeen UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1571-0692","authenticated-orcid":false,"given":"Ceri","family":"Bygrave","sequence":"additional","affiliation":[{"name":"Cardiff and Vale UHB  Cardiff UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5765-8941","authenticated-orcid":false,"given":"Oonagh","family":"Sheehy","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust  Belfast UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25791"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.014"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903455"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01188-9"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32292-3"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.07.016"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S341120"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17076"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.advms.2019.05.001"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13712"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04374-y"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0756-6"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.12.026"}],"container-title":["eJHaem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jha2.913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:19:08Z","timestamp":1739355548000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jha2.913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1002\/jha2.913"],"URL":"https:\/\/doi.org\/10.1002\/jha2.913","archive":["Portico"],"relation":{},"ISSN":["2688-6146","2688-6146"],"issn-type":[{"type":"print","value":"2688-6146"},{"type":"electronic","value":"2688-6146"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"2023-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}